CID 203892

Piperazine, 1-(2-(9,10-ethanoanthracen-9(10h)-yloxy)ethyl)-4-methyl-, dihydrochloride

Structural Information

Molecular Formula
C23H28N2O
SMILES
CN1CCN(CC1)CCOC23CCC(C4=CC=CC=C42)C5=CC=CC=C35
InChI
InChI=1S/C23H28N2O/c1-24-12-14-25(15-13-24)16-17-26-23-11-10-18(19-6-2-4-8-21(19)23)20-7-3-5-9-22(20)23/h2-9,18H,10-17H2,1H3
InChIKey
ACCUGXYBVJSKPH-UHFFFAOYSA-N
Compound name
1-methyl-4-[2-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyloxy)ethyl]piperazine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

348.22015 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 349.227426 182.2
[M+Na]+ 371.209368 184.5
[M-H]- 347.212874 182.9
[M+NH4]+ 366.253973 198.1
[M+K]+ 387.183308 178.3
[M+H-H2O]+ 331.217410 168.6
[M+HCOO]- 393.218351 188.1
[M+CH3COO]- 407.234001 188.5
[M+Na-2H]- 369.194816 189.3
[M]+ 348.21960142 180.4
[M]- 348.22069858 180.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe